Sort
23,748 grants matching “melanoma”
Defining Transcriptional Regulators of Melanoma Initiation using Zebrafish
$356,827Charles Kore Kaufman · Washington University · R01 · FY2019 · CA
Core 1: Clinicopathological Analysis and Disease Modeling
$356,808Iman Osman · New York University School Of Medicine · U54 · FY2023 · CA
Nuclear receptors: action, functions, and roles in disease
$356,770Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Mutant BRAF-regulated transcription factors in melanoma progression
$356,660Andrew E Aplin · Thomas Jefferson University · R01 · FY2015 · CA
Biomaterials-based metabolic rescue of dendritic cells for vaccine design
$356,647Abhinav Acharya · Case Western Reserve University · R01 · FY2025 · AI
MET Activation in Melanoma Genesis and Progression
$356,631Dana-Farber Cancer Institute · R01 · FY2004 · CA
MET Activation in Melanoma Genesis and Progression
$356,631Dana-Farber Cancer Institute · R01 · FY2003 · CA
MET Activation in Melanoma Genesis and Progression
$356,631Dana-Farber Cancer Institute · R01 · FY2005 · CA
Mechanism of Normal and Ocogenic Kit Signaling in Vivo
$356,625Sloan-Kettering Institute For Cancer Res · R01 · FY2003 · HL
Mechanism of Normal and Ocogenic Kit Signaling in Vivo
$356,625Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · HL
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$356,587Yi Lin · Mayo Clinic Rochester · R01 · FY2019 · CA
Characterization of Mutagenesis, Mutational Spectra and Mechanisms of Toxicity
$356,563Gerald N Wogan · Massachusetts Institute Of Technology · P01 · FY2012 · CA
Strategies for Receptor inhibition in immunotherapy
$356,553Kenan Christopher Garcia · Stanford University · R01 · FY2024 · CA
Estrogen receptor beta is a targetable melanoma tumor suppressor
$356,540Craig J Burd · Ohio State University · R01 · FY2025 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$356,438Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2022 · CA
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$356,409Ryan Bruce Corcoran · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Dietary trans-vaccenic acid enhances anti-tumor immunity
$356,393Jing Chen · University Of Chicago · R01 · FY2024 · CA
Estrogen receptor beta is a targetable melanoma tumor suppressor
$356,359Craig J Burd · Ohio State University · R01 · FY2022 · CA
PAX3 pathways in melanoma
$356,330Deborah Lang · University Of Chicago · R01 · FY2015 · CA
Project 3: Predicting therapeutic sensitivity in cancer
$356,263Anna Lasorella · Columbia University Health Sciences · U54 · FY2019 · CA
Development of sensory axon pathways in zebrafish
$356,220Mary C Halloran · University Of Wisconsin-Madison · R56 · FY2007 · NS
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$356,184Ann Richmond · Vanderbilt University · R01 · FY2022 · CA
Optimizing Response to Immune Checkpoint Inhibitor Therapy for Breast Cancer: A Role for Inhibitors of the PI3K pathway
$356,184Ann Richmond · Vanderbilt University · R01 · FY2023 · CA
NHGRI/DIR Microarray Core
$355,984Abdel Elkahloun · National Human Genome Research Institute · ZIC · FY2015 · HG
Reprogramming of the stromal microenvironment in melanoma progression and therapeutic escape
$355,954Yuhang Zhang · University Of Cincinnati · R01 · FY2023 · CA